Oncimmune Holdings PLC Total Voting Rights (7656K)
January 06 2021 - 4:27AM
UK Regulatory
TIDMONC
RNS Number : 7656K
Oncimmune Holdings PLC
06 January 2021
6 January 2021
Oncimmune Holdings plc
("Oncimmune" or the "Company")
Total Voting Rights
In accordance with the Disclosure Guidance and Transparency
Rules (DTR 5.6), Oncimmune makes the following disclosure with
respect to the share capital and voting rights of the Company.
As at 31 December 2020, the Company's issued share capital was
63,662,446 ordinary shares of GBP0.01 each with voting rights. The
Company does not hold any shares in treasury.
The above figure of 63,662,446 may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in the Company under the FCA's Disclosure Guidance
and Transparency Rules.
For further information:
Oncimmune Holdings plc
Ron Kirschner, Company Secretary
contact@oncimmune.co.uk
Zeus Capital Limited (Nominated Adviser and Joint Broker)
Andrew Jones, Daniel Harris, Victoria Ayton
+44 (0)20 3829 5000
N+1 Singer (Joint Broker)
Aubrey Powell, Harry Gooden, Iqra Amin, James Fischer
+44 (0)20 7496 3000
WG Partners (Joint Broker)
David Wilson, Chris Lee
+44 (0)203 705 9321
Media enquiries:
FTI Consulting
Ben Atwell, Michael Trace, Alex Davis
Oncimmune@fticonsulting.com
+44 (0)20 3727 1000
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVREAEFKEAKFEFA
(END) Dow Jones Newswires
January 06, 2021 05:27 ET (10:27 GMT)
Oncimmune (LSE:ONC)
Historical Stock Chart
From Apr 2024 to May 2024
Oncimmune (LSE:ONC)
Historical Stock Chart
From May 2023 to May 2024
